RankAlpha logo
Back to Rankings

XGN

ExagenD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
XGN vs peer average
51/100
XGN vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · F 8
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CUE is the first available peer comparator.

Cue Biopharma is mainly a therapeutics developer, so it is only a loose small-cap biotech risk-capital comparator rather than a direct peer for diagnostics volume, pricing, or reimbursement execution.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCUECue Biopharma
XGN
Exagen
CUE
Cue Biopharma
Grade
D
F
Momentum
99
46
Value
41
41
Sentiment
35
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CUE

XGN / CUE
Grade Position
In line
XGN vs. peer average (D vs. D)
51/100
Momentum
99
XGN
Value
41
XGN
Sentiment
35
XGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XGN
1
CUE
CUE
F
20/100
+1
2
BDTX
BDTX
B
80/100
-2
3
ONCY
ONCY
F
20/100
+1
4
QSI
Quantum-Si Inc Class A Common
F
20/100
+1
5
CNTN
Canton Strategic Holdings Inc Common
F
20/100
+1
CUE is the first peer returned for this comparison set.